Search

everythinglearnresearchcommunity

for

Search:↓

A new microneedle patch significantly improves melanoma treatment by using a special material to activate cancer-fighting drugs and disrupt cancer cells.

A new mutation in the mitochondrial DNA was found in a boy with MELAS, even though his family didn't show typical signs.

Tebentafusp-tebn improves survival rates in uveal melanoma patients but has common side effects like rash and fatigue.

BBR-SA nanomedicine is a safe and effective treatment for breast cancer.

Adding dutasteride to therapy may improve treatment for advanced salivary duct cancer.

PH-762 shows promise in treating skin cancer by effectively targeting and silencing PD-1 in tumors with minimal side effects.

Inhibiting mTORC2 can reduce DNA repair and increase cancer cell death, suggesting potential for targeted brain cancer treatments.

Scale created to measure hair loss in men and women; MK-386 reduces acne; Niaspan treats dyslipidemia; minoxidil increases heart rate.

A new microneedle system effectively delivers a vasodilator to hair follicles, promoting hair growth better than current treatments.

The new AI software predicts melanoma outcomes more accurately than traditional methods.

Arumanis mango rind extract and its fractions can kill breast cancer cells, especially the ethanol extract and ethyl acetate fraction.

The new device improves surgical accuracy by using a special dye and camera to see inside tissues.

Analog 23 is a promising compound for prostate cancer treatment.

BLZ-100 is safe for use in skin cancer surgery and may help identify cancerous tissue.

The scaffold effectively prevents melanoma relapse and aids wound healing.

New sensor detects minoxidil accurately and effectively.

Mitochondrial genes help predict breast cancer outcomes and spread.

Polydopamine is promising for personalized medicine and biomedical technology due to its strong adhesion and biocompatibility.

The report expanded knowledge of MBTPS1-related disorders by identifying new symptoms.

ALRN-6924 may prevent hair loss caused by chemotherapy.

A rare genetic mutation caused severe symptoms in a 6-year-old girl with mandibuloacral dysplasia type A.

HtrA2 activity is crucial for normal hair growth by regulating fat cell development.

M50054 may help treat hepatitis and hair loss from chemotherapy.

The study developed a 3D model that closely imitates remaining ovarian cancer after treatment and identified a potential drug targeting resistant cancer cells.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Specific mutations in a receptor cause facial abnormalities and hair loss.

A dissolving microneedle patch with dutasteride offers effective, long-lasting hair loss treatment with fewer side effects.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.